In the case of ectopic oversecretion of FGF23, including TIO, in which FGF23 is secreted from PMTs originating in soft or skeletal tissue, FGF23 expression in normal bone should be suppressed to compensate for hypophosphatemia. This evidence concerns the gene FGF23 and hypophosphatemia.